Cargando…

The burden of exacerbations in mild asthma: a systematic review

BACKGROUND: Although most patients with asthma have mild disease, data on how mild asthma is defined, and how frequently exacerbations occur in this patient population are scarce, so we aimed to redress this. METHODS: We searched Medline and Medline In-Process (PubMed), and Embase in OVID for Englis...

Descripción completa

Detalles Bibliográficos
Autores principales:	FitzGerald, J. Mark, Barnes, Peter J., Chipps, Bradley E., Jenkins, Christine R., O'Byrne, Paul M., Pavord, Ian D., Reddel, Helen K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418821/ https://www.ncbi.nlm.nih.gov/pubmed/32802826 http://dx.doi.org/10.1183/23120541.00359-2019

Ejemplares similares

Positioning As-needed Budesonide–Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2
por: Bateman, Eric D., et al.
Publicado: (2021)

The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given ‘as needed’ in mild asthma: study protocols for two randomised controlled trials
por: O’Byrne, Paul M., et al.
Publicado: (2017)

Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies
por: FitzGerald, J. Mark, et al.
Publicado: (2021)

Current recommendations for the treatment of mild asthma
por: Shahidi, Neal, et al.
Publicado: (2010)

Perspectives of mild asthma patients on maintenance versus as-needed preventer treatment regimens: a qualitative study
por: Foster, Juliet, et al.
Publicado: (2022)

The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Economic burden of asthma: a systematic review
por: Bahadori, Katayoun, et al.
Publicado: (2009)

The Projected Economic and Health Burden of Uncontrolled Asthma in the United States
por: Yaghoubi, Mohsen, et al.
Publicado: (2019)

Asthma exacerbations and worsenings in patients aged 1–75 years with add-on tiotropium treatment
por: Mark FitzGerald, J., et al.
Publicado: (2020)

Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials
por: Chen, Wenjia, et al.
Publicado: (2023)

Risk factors of hospitalization and readmission of patients with COPD exacerbation – systematic review
por: Bahadori, Katayoon, et al.
Publicado: (2007)

Updated Australian guidelines for mild asthma: what’s changed and why?
por: Reddel, Helen K
Publicado: (2020)

Asthma guidelines: Global to local
por: FitzGerald, J. Mark
Publicado: (2009)

Asthma progression and mortality: the role of inhaled corticosteroids
por: O'Byrne, Paul, et al.
Publicado: (2019)

Achieving asthma control: Providing a framework for clinicians
por: FitzGerald, J. Mark
Publicado: (2016)

A systematic review of economic evaluations of therapy in asthma
por: Bahadori, Katayoun, et al.
Publicado: (2010)

The role of asthma guidelines in achieving current control and reducing future risk
por: FitzGerald, J. Mark
Publicado: (2012)

Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma
por: Gauvreau, Gail M., et al.
Publicado: (2023)

Heterogeneity's ruses: the neglected role of between-individual variability in longitudinal studies of COPD exacerbations
por: Sadatsafavi, Mohsen, et al.
Publicado: (2014)

Dupilumab efficacy in adolescents with uncontrolled, moderate‐to‐severe asthma: LIBERTY ASTHMA QUEST
por: Maspero, Jorge F., et al.
Publicado: (2021)

OX40L blockade and allergen-induced airway responses in subjects with mild asthma
por: Gauvreau, G M, et al.
Publicado: (2014)

Questions in Mild Asthma: An Official American Thoracic Society Research Statement
por: Mohan, Arjun, et al.
Publicado: (2023)

Extent, trends, and determinants of controller/reliever balance in mild asthma: a 14-year population-based study
por: Khakban, Amir, et al.
Publicado: (2019)

Asthma impacts on workplace productivity in employed patients who are symptomatic despite background therapy: a multinational survey
por: Gruffydd-Jones, Kevin, et al.
Publicado: (2019)

Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort
por: Chipps, Bradley E., et al.
Publicado: (2012)

A summary of the new GINA strategy: a roadmap to asthma control
por: Reddel, Helen K., et al.
Publicado: (2015)

The Myth of Mild: Severe Exacerbations in Mild Asthma: An Underappreciated, but Preventable Problem
por: Kaplan, Alan
Publicado: (2021)

Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps
por: Bateman, Eric D, et al.
Publicado: (2011)

Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
por: Zafari, Zafar, et al.
Publicado: (2018)

A parametric model to jointly characterize rate, duration, and severity of exacerbations in episodic diseases
por: Safari, Abdollah, et al.
Publicado: (2023)

Post-hospital syndrome in adults with asthma: a case-crossover study
por: Sadatsafavi, Mohsen, et al.
Publicado: (2013)

Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment
por: Jenkins, Christine R., et al.
Publicado: (2017)

Functional genomics of the peripheral blood response to allergen inhalation challenge
por: Kam, Sarah HY, et al.
Publicado: (2010)

Complementary and alternative asthma treatments and their association with asthma control: a population-based study
por: Chen, Wenjia, et al.
Publicado: (2013)

Common conditions that mimic asthma
por: Reddel, Helen K
Publicado: (2022)

Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis
por: Loymans, Rik J B, et al.
Publicado: (2014)

Understanding the Clinical Implications of Individual Patient Characteristics and Treatment Choice on the Risk of Exacerbation in Asthma Patients with Moderate–Severe Symptoms
por: Singh, Dave, et al.
Publicado: (2023)

Antibiotic consumption in children prior to diagnosis of asthma
por: Marra, Fawziah, et al.
Publicado: (2011)

Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis
por: Alshabanat, A., et al.
Publicado: (2015)

Burden of asthma exacerbations and health care utilization in pediatric patients with asthma in the US and England
por: Gokhale, Mugdha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nbr3ubo1jccos35eerlmtkc1jd